Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockman6767on Jan 09, 2018 2:56pm
358 Views
Post# 27315955

RE:RE:RE:RE:RE:RE:Ryplazim Approval - Could Come Any Time

RE:RE:RE:RE:RE:RE:Ryplazim Approval - Could Come Any TimeI was told the same by Fred in an email in early Dec 2017. I had initially misunderstood that response, but now, rereading it, it clealry coincides with what you and Barcode are saying. He also ponted out that the inspection was a fourth quarter event. I took this to mean that it had not happened yet, but there is still time for it to happen during the rest of Dec. Today, I am not certain whether it did or did not happen, but based on that email it is very possible and indeed likely  that it did in fact ocur in Dec after that email, but was simply not reported to the public since it is only one part of the larger onging reulatory process for the BLA.
Bullboard Posts